THE CLINIC
SECTION 12
ISSUE 001
Trial Simulators Before Patient Exposure
Projection: simulation cohorts will become the wind tunnels of clinical-AI trials, exposing brittle recruitment plans, missing-data assumptions, subgroup gaps, and workflow failures before patients are enrolled. They must never substitute for real trials. Their value is choosing safer, more informative experiments before the ethical stakes become irreversible.
Why this idea is here
What the evidence establishes.
NIH is developing multimodal AI-ready datasets; FDA guidance emphasizes study appropriateness, safety, effectiveness, and lifecycle evidence for medical software.
Source ledger
Read the sources.
- S01NIH Common Fund Bridge2AI Program Advances to Next Stage
official program announcement / published 2026-01-30 / retrieved 2026-07-09
- S02Artificial Intelligence-Enabled Medical Devices
official regulatory database / dated Live source · verified 2026-07-09 / retrieved 2026-07-09